R2696 Pill - yellow capsule/oblong
Pill with imprint R2696 is Yellow, Capsule/Oblong and has been identified as Ramipril 5 mg. It is supplied by Actavis.
Ramipril is used in the treatment of High Blood Pressure; Diabetic Kidney Disease; Left Ventricular Dysfunction; Cardiovascular Risk Reduction; Heart Failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Ramipril 5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for R2696
Ramipril
- Imprint
- R2696
- Strength
- 5 mg
- Color
- Yellow
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Angiotensin Converting Enzyme Inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- National Drug Code (NDC)
- 00228-2696 (Discontinued)
More about ramipril
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (133)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Angiotensin Converting Enzyme Inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.